Skip to main content
HYPD
NASDAQ Life Sciences

Hyperion DeFi Reports Record Q1 Net Income, Raises FY26 Guidance, and Boosts Cash Reserves

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$3.5
Mkt Cap
$39.871M
52W Low
$1.08
52W High
$17.18
52W Position info
224% above low
Off High info
80% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

HYPD has more than doubled off its 52-week low of $1.08.

Summary

Hyperion DeFi reported record Q1 2026 net income and Adjusted EBITDA, significantly raised its full-year guidance, and substantially increased its cash reserves, signaling a strong financial turnaround.


Key Events · Earnings and Guidance · HYPD

  • Record Q1 2026 Financial Results

    The company reported a net income of $8.8 million and Adjusted EBITDA of $19.5 million for Q1 2026, a significant turnaround from the previous quarter's net loss of ($39.8 million) and Adjusted EBITDA of ($38.9 million).

  • Full-Year 2026 Guidance Raised

    Hyperion DeFi increased its full-year 2026 Adjusted Gross Profit guidance from a range of $4M-$6M to $5M-$7M, reflecting improved operational outlook.

  • Substantial Increase in Cash Reserves

    Cash, cash equivalents, and USDH grew to approximately $16.0 million as of May 11, 2026, up from $9.1 million at the end of Q1 2026 and $6.5 million at the end of Q4 2025.

  • Underwriter Option Exercise

    The company issued 132,249 shares of common stock to Chardan Capital Markets, LLC, generating approximately $0.4 million in net proceeds from the exercise of a 30-day over-allotment option related to a prior offering.


Analysis · HYPD · Life Sciences

Hyperion DeFi announced a significant financial turnaround for Q1 2026, reporting record net income of $8.8 million and Adjusted EBITDA of $19.5 million. This marks a dramatic improvement from the previous quarter's substantial losses and follows recent disclosures of digital asset impairment and material weaknesses in internal controls. The company also raised its full-year 2026 Adjusted Gross Profit guidance from $4M-$6M to $5M-$7M, indicating increased confidence in its DeFi operating segments. Furthermore, cash, cash equivalents, and USDH reserves grew to $16.0 million as of May 11, 2026, significantly strengthening its liquidity. The filing also noted the exercise of an underwriter's option, resulting in the issuance of 132,249 shares and approximately $0.4 million in net proceeds, a minor dilutive event compared to the strong financial performance.

How filings like this one have moved

In the 30 days to Nov 10, 2026, 52.5% of the 204 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.68%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HYPD was trading at $3.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $39.9M. The 52-week trading range was $1.08 to $17.18. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HYPD - Latest Insights

HYPD
Oct 02, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.61
Real-time Price: $2.58 info
Change: -$1.03 (-29%) info
Market Cap: $40.092M info
HYPD
Sep 08, 2026, 8:12 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.41
Real-time Price: $2.58 info
Change: -$0.8257 (-24%) info
Market Cap: $40.092M info
HYPD
Aug 12, 2026, 8:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.83
Real-time Price: $2.58 info
Change: -$0.250 (-9%) info
Market Cap: $40.092M info
HYPD
Aug 12, 2026, 4:15 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.82
Real-time Price: $2.58 info
Change: -$0.2441 (-9%) info
Market Cap: $40.092M info
HYPD
Aug 12, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.79
Real-time Price: $2.58 info
Change: -$0.210 (-8%) info
Market Cap: $40.092M info